Key Takeaways

Eli Lilly and OpenAI Team Up: A strategic partnership aims to accelerate the discovery of new antibiotics using generative AI.

Figma's Major Redesign: Figma introduces new AI features to streamline the design process, including automatic layer organization and interactive prototyping.

ChatGPT's Advanced Voice Mode Delayed: OpenAI postpones the rollout of its new voice capabilities to improve safety and scalability.


In today's episode of The AI Briefing, we explore the innovative partnership between pharmaceutical giant Eli Lilly and AI leader OpenAI. The collaboration focuses on leveraging OpenAI’s generative AI technology to rapidly discover new antibiotics to combat antimicrobial resistance, a significant global health issue. The goal is an ambitious one: to develop 2-4 new antibiotics by 2030.
Next, we discuss Figma's latest major redesign unveiled at their Config 2024 conference. The update introduces a suite of new AI-powered features that include generating UI mocks from text prompts, conducting visual searches using images or screenshots, and even turning static designs into interactive prototypes automatically. These new capabilities aim to streamline workflows and empower designers to break through creative blocks more effectively.
Finally, we cover the news that OpenAI has delayed the launch of ChatGPT's advanced voice mode. Originally planned for a late June release, the rollout has been postponed by a month to enhance the model’s content detection capabilities and ensure scalability. The feature will initially enter an alpha testing phase in July with a small user group before broader access is granted later in the fall, pending performance against safety and reliability standards.
ℹ️ The AI Briefing is an AI-generated podcast we created as an experiment to uncover what is and is not possible for automating the podcast production process. Information disclosed in the podcast episode is hand-picked and reviewed by humans prior to the episodes being created. We appreciate any feedback you have and appreciate you tuning in.

Sources
https://www.nasdaq.com/articles/eli-lilly-collaborates-openai-use-generative-ai-invent-novel-antimicrobials
https://investor.lilly.com/news-releases/news-release-details/lilly-collaborates-openai-discover-novel-medicines-treat-drug
https://www.theverge.com/2024/6/26/24183730/figma-ai-tools-app-redesign-slides
https://bgr.com/tech/figma-announces-redesign-ai-integration-and-more-at-config-2024/
https://venturebeat.com/ai/openai-delays-release-of-new-chatgpt-voice-mode-by-at-least-one-month/
https://techmonitor.ai/technology/ai-and-automation/openai-delays-voice-feature-chatgpt